Automation Leadership DYNEX's long-standing leadership in fully automated ELISA microplate systems, US-manufactured and ISO-certified, enables high throughput and precise results. Their capability to support diverse sample types and a broad library of validated protocols allows labs—from hospitals to contract research organizations—to scale operations and accelerate testing pipelines. This creates opportunities to engage pharma and biotech, CROs, and clinical labs seeking automation upgrades, LIMS integration, and faster turnaround times.

Broad Protocols With a wide catalog of established protocols and the ability to run commercial kits and lab-developed tests on the same platform, DYNEX offers a flexible automation backbone for labs diversifying test menus or standardizing workflows. This supports cross-selling of assay development services, training, and platform expansion to accommodate new disease panels, multiplex testing, and custom workflows for labs transitioning from manual ELISA or seeking single-platform efficiency.

Strategic Partnerships Recent collaboration with Tecan and a history of expansions indicate a robust partner-driven go-to-market and R&D strategy. Opportunities exist to deepen channel partnerships with distributors and system integrators, leveraging joint marketing and bundled offerings to reach regional hospitals, research centers, and pharmaceutical QC labs across North America and Europe. There is also potential to co-develop assays with ecosystem players.

Target Markets Primary opportunities lie in pharma and biotech manufacturing QC labs, CROs, contract testing facilities, and clinical labs requiring high-throughput ELISA. The Agility Integra launch highlights speed and flexibility as differentiators, enabling sales motions around throughput, assay diversity, and regulatory-grade performance. Tailor messaging to labs needing automated, scalable ELISA for multi-disease panels and LDT compatibility.

Growth Opportunities The company shows growth signals through new product introductions, European expansion, and a diversified revenue base. This creates opportunities to upsell service contracts, calibration and maintenance, training programs, and spare parts through value-based service offerings. Emphasize total cost of ownership and long-term support to secure multi-year commitments with mid-market labs.